» Articles » PMID: 23137800

Altered Auditory Processing in Frontal and Left Temporal Cortex in 22q11.2 Deletion Syndrome: a Group at High Genetic Risk for Schizophrenia

Overview
Journal Psychiatry Res
Specialty Psychiatry
Date 2012 Nov 10
PMID 23137800
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

In order to investigate electroencephalographic (EEG) biomarkers of auditory processing for schizophrenia, we studied a group with a well known high-risk profile: patients with 22q11.2 deletion syndrome (22q11 DS) have a 30% risk of developing schizophrenia during adulthood. We performed high-density EEG source imaging to measure auditory gating of the P50 component of the evoked potential and middle to late latency auditory processing in 21 participants with the 22q11.2 deletion and 17 age-matched healthy controls. While we found no indication of altered P50 suppression in 22q11 DS, we observed marked differences for the first N1 component with increased amplitudes on central electrodes, corresponding to increased activations in dorsal anterior cingulate and medial frontal cortex. We also found a left lateralized reduction of activation of primary and secondary auditory cortex during the second N1 (120ms) and the P2 component in 22q11 DS. Our results show that sensory gating and activations until 50ms were preserved in 22q11 DS, while impairments appear at latencies that correspond to higher order auditory processing. While the increased activation of cingulate and medial frontal cortex could reflect developmental changes in 22q11 DS, the reduced activity seen in left auditory cortex might serve as a biomarker for the development of schizophrenia, if confirmed by longitudinal research protocols.

Citing Articles

Neurophysiological Markers of Auditory Verbal Hallucinations in Patients with Schizophrenia: An EEG Microstates Study.

Li S, Hu R, Yan H, Chu L, Qiu Y, Gao Y Brain Topogr. 2025; 38(2):29.

PMID: 39920494 DOI: 10.1007/s10548-025-01105-2.


Auditory evoked-potential abnormalities in a mouse model of 22q11.2 Deletion Syndrome and their interactions with hearing impairment.

Lu C, Linden J Transl Psychiatry. 2025; 15(1):4.

PMID: 39779687 PMC: 11711659. DOI: 10.1038/s41398-024-03218-x.


Event-related potential (ERP) markers of 22q11.2 deletion syndrome and associated psychosis.

Francisco A, Foxe J, Molholm S J Neurodev Disord. 2023; 15(1):19.

PMID: 37328766 PMC: 10273715. DOI: 10.1186/s11689-023-09487-9.


Early visual processing and adaptation as markers of disease, not vulnerability: EEG evidence from 22q11.2 deletion syndrome, a population at high risk for schizophrenia.

Francisco A, Foxe J, Horsthuis D, Molholm S Schizophrenia (Heidelb). 2022; 8(1):28.

PMID: 35314711 PMC: 8938446. DOI: 10.1038/s41537-022-00240-0.


Mutations associated with neuropsychiatric conditions delineate functional brain connectivity dimensions contributing to autism and schizophrenia.

Moreau C, Urchs S, Kuldeep K, Orban P, Schramm C, Dumas G Nat Commun. 2020; 11(1):5272.

PMID: 33077750 PMC: 7573583. DOI: 10.1038/s41467-020-18997-2.